For example, Parvimonas micra is thought to be associated with reduced survival in colorectal cancer (CRC) patients and may promote CRC progression by activating the Ras/ERK/c-Fos pathway (Zhao et al., 2022; Chang et al., 2023). Here, FOS is linked to colorectal carcinoma.